We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




The Future for Laboratory Technology Unveiled

By LabMedica International staff writers
Posted on 19 Mar 2012
Print article
Biomedical laboratories need to be able to deal with a high throughput of samples while reliably documenting each step in the testing process.

The fact that it takes so long for laboratories to analyze samples is in no small part due to all the cumbersome paperwork as each sample must be accompanied by meticulous records.

At the Fraunhofer Institute for Biomedical Engineering (IBMT; St. Ingbert, Germany) scientists are developing a fully automated approach to testing, with a particular emphasis on automating the documenting of samples. The main aim is to enable sample data to be processed automatically. A tiny microchip is embedded in the plastic of the test tube and used to store all relevant information, such as when and where a sample is from and the patient's name. In the past, test tubes would be written on by hand; more recently, the data has been stored in a barcode for easy scanning.

When the test tube is placed into an analyzer, the equipment can record details on the embedded chip of exactly what went on in the analysis. This means the test tube itself carries the sample's entire history, with no need for technicians to write up a laborious report including the patient's details, the results of the analysis and the testing methods employed. Scientists at IBMT are working together with Soventec GmbH (Dannewerk, Germany) to develop the LabOS laboratory management system. Working with LabOS, as soon as a test tube is placed in a reader, a screen displays data on the sample's history and also what the next steps are without the need for any paperwork.

Daniel Schmitt, Dipl. Phys., a project leader for the IBMT, said, "Usually, samples are accompanied by a report slip. Alternatively, the laboratory will know to expect a sample when it receives an e-mail containing all the necessary information. With test tube chips, the sample and the information are inseparably linked, and there is no way for information to go astray." For some time now, the project partners have been able to demonstrate just how well all this technology works together thanks to a mobile laboratory. Housed in a truck that is traveling all over South Africa, it is mainly working to diagnose AIDS and tuberculosis. The scientists showed the effectiveness of their concept at the MEDTEC Europe trade fair in Stuttgart, Germany from March 13 to 15, 2012.

Related Links:

Fraunhofer Institute for Biomedical Engineering
Soventec GmbH


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.